Literature DB >> 18983495

African-American ethnicity is associated with higher plasma levels of D-dimer in adults with hypertension.

M Khaleghi1, U Saleem, R D McBane, T H Mosley, I J Kullo.   

Abstract

BACKGROUND: African Americans with hypertension have higher cardiovascular morbidity and mortality than hypertensives from other ethnic groups. Plasma D-dimer, a fragment generated from fibrin during lysis of mature clot in vivo, is a predictor of adverse cardiovascular events.
OBJECTIVE: We investigated whether plasma levels of D-dimer differ between African American (AA) and non-Hispanic white (NHW) adults with hypertension.
METHODS: Participants included 933 AA (65 +/- 9 years, 72% women) and 821 NHW (61 +/- 9 years, 56% women) from the community. D-dimer was measured using an immunoturbidimetric assay. Multivariable regression analyses, stratified by gender, were performed to assess whether AA ethnicity was associated with D-dimer levels after adjustment for age, body mass index (BMI), total and high-density lipoprotein (HDL) cholesterol, systolic blood pressure, diabetes, history of smoking, medication (statin and aspirin) use, lifestyle variables (physical activity, alcohol intake, and education), estimated glomerular filtration rate (eGFR), and a marker of inflammation, C-reactive protein (CRP).
RESULTS: D-dimer levels were higher in AA men and women than in their NHW counterparts (mean +/- SD; men 256 +/- 199 vs. 190 +/- 183 ng mL(-1), P < 0.001; women, 290 +/- 233 vs. 225 +/- 195 ng mL(-1), P < 0.001). In both sexes, after adjustment for age, conventional risk factors, medication use, and lifestyle variables, AA ethnicity remained associated with higher D-dimer levels (P = 0.002 in men, P = 0.006 in women). These associations remained significant after additional adjustment for eGFR and plasma CRP (P = 0.003 in men, P < 0.0001 in women).
CONCLUSIONS: Among adults with hypertension, AA ethnicity was independently associated with higher plasma levels of D-dimer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18983495      PMCID: PMC2858060          DOI: 10.1111/j.1538-7836.2008.03215.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  42 in total

Review 1.  Inflammation and coagulation: linked processes potentially regulated through a common pathway mediated by protein C.

Authors:  C T Esmon; F B Taylor; T R Snow
Journal:  Thromb Haemost       Date:  1991-07-12       Impact factor: 5.249

2.  IL-6 functions as an exocrine hormone in inflammation. Hepatocytes undergoing acute phase responses require exogenous IL-6.

Authors:  J Gauldie; W Northemann; G H Fey
Journal:  J Immunol       Date:  1990-05-15       Impact factor: 5.422

3.  Longitudinal data analysis for discrete and continuous outcomes.

Authors:  S L Zeger; K Y Liang
Journal:  Biometrics       Date:  1986-03       Impact factor: 2.571

4.  Regulation of fibrinogen synthesis by plasmin-derived fragments of fibrinogen and fibrin: an indirect feedback pathway.

Authors:  D G Ritchie; B A Levy; M A Adams; G M Fuller
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

5.  Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease.

Authors:  F G Fowkes; G D Lowe; E Housley; A Rattray; A Rumley; R A Elton; I R MacGregor; J Dawes
Journal:  Lancet       Date:  1993-07-10       Impact factor: 79.321

6.  Fibrin degradation product D-dimer induces the synthesis and release of biologically active IL-1 beta, IL-6 and plasminogen activator inhibitors from monocytes in vitro.

Authors:  S C Robson; E G Shephard; R E Kirsch
Journal:  Br J Haematol       Date:  1994-02       Impact factor: 6.998

7.  Relation of levels of hemostatic factors and inflammatory markers to the ankle brachial index.

Authors:  Mary M McDermott; David Green; Philip Greenland; Kiang Liu; Michael H Criqui; Cheeling Chan; Jack M Guralnik; William H Pearce; Paul M Ridker; Lloyd Taylor; Nader Rifai; Joseph R Schneider
Journal:  Am J Cardiol       Date:  2003-07-15       Impact factor: 2.778

8.  Coagulation system activation and increase of D-dimer levels in peripheral arterial occlusive disease.

Authors:  M De Buyzere; J Philippé; D Duprez; G Baele; D L Clement
Journal:  Am J Hematol       Date:  1993-06       Impact factor: 10.047

9.  D-dimer, inflammatory markers, and lower extremity functioning in patients with and without peripheral arterial disease.

Authors:  Mary McGrae McDermott; Philip Greenland; David Green; Jack M Guralnik; Michael H Criqui; Kiang Liu; Cheeling Chan; William H Pearce; Lloyd Taylor; Paul M Ridker; Joseph R Schneider; Gary Martin; Nader Rifai; Maureen Quann; Myriam Fornage
Journal:  Circulation       Date:  2003-06-16       Impact factor: 29.690

10.  Plasma D dimer: a useful marker of fibrin breakdown in renal failure.

Authors:  M P Gordge; R W Faint; P B Rylance; H Ireland; D A Lane; G H Neild
Journal:  Thromb Haemost       Date:  1989-06-30       Impact factor: 5.249

View more
  14 in total

1.  Brief Report: Racial Comparison of D-Dimer Levels in US Male Military Personnel Before and After HIV Infection and Viral Suppression.

Authors:  Thomas A OʼBryan; Brian K Agan; Russell P Tracy; Matthew S Freiberg; Jason F Okulicz; Kaku So-Armah; Anuradha Ganesan; David Rimland; Tahaniyat Lalani; Robert G Deiss; Edmund C Tramont
Journal:  J Acquir Immune Defic Syndr       Date:  2018-04-15       Impact factor: 3.731

2.  Associations of D-dimer and von Willebrand factor with atherosclerosis in Japanese and white men.

Authors:  Ryoko W Azuma; Takashi Kadowaki; Aiman El-Saed; Hirotsugu Ueshima; Kim Sutton-Tyrrell; Yasuyuki Nakamura; Daniel Edmundowicz; Yoshiki Ueno; Rhobert W Evans; Aya Kadota; Lewis H Kuller; Kiyoshi Murata; Tomoko Takamiya; Sayaka Kadowaki; J David Curb; Akira Sekikawa
Journal:  Acta Cardiol       Date:  2010-08       Impact factor: 1.718

3.  Pharmacological approaches to the treatment of COVID-19 patients.

Authors:  Lawrence C Sowers; Lucas S Blanton; Scott C Weaver; Randall J Urban; Charles P Mouton
Journal:  J Transl Sci       Date:  2020-04-17

4.  D-Dimer in African Americans: Whole Genome Sequence Analysis and Relationship to Cardiovascular Disease Risk in the Jackson Heart Study.

Authors:  Laura M Raffield; Neil A Zakai; Qing Duan; Cecelia Laurie; Joshua D Smith; Marguerite R Irvin; Margaret F Doyle; Rakhi P Naik; Ci Song; Ani W Manichaikul; Yongmei Liu; Peter Durda; Jerome I Rotter; Nancy S Jenny; Stephen S Rich; James G Wilson; Andrew D Johnson; Adolfo Correa; Yun Li; Deborah A Nickerson; Kenneth Rice; Ethan M Lange; Mary Cushman; Leslie A Lange; Alex P Reiner
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-09-14       Impact factor: 8.311

5.  Self-identified Race and COVID-19-Associated Acute Kidney Injury and Inflammation: a Retrospective Cohort Study of Hospitalized Inner-City COVID-19 Patients.

Authors:  Nipith Charoenngam; Titilayo O Ilori; Michael F Holick; Natasha S Hochberg; Caroline M Apovian
Journal:  J Gen Intern Med       Date:  2021-06-07       Impact factor: 5.128

6.  Inflammation and its associations with aortic stiffness, coronary artery disease and peripheral artery disease in different ethnic groups: The HELIUS Study.

Authors:  Charles F Hayfron-Benjamin; Charlotte Mosterd; Anke H Maitland-van der Zee; Daniel H van Raalte; Albert G B Amoah; Charles Agyemang; Bert-Jan van den Born
Journal:  EClinicalMedicine       Date:  2021-07-07

7.  Racial disparities in COVID-19 associated pulmonary embolism: A multicenter cohort study.

Authors:  Brandon Metra; Ross Summer; Sandra Elaine Brooks; Gautam George; Baskaran Sundaram
Journal:  Thromb Res       Date:  2021-07-03       Impact factor: 3.944

8.  Factors associated with D-dimer levels in HIV-infected individuals.

Authors:  Alvaro H Borges; Jemma L O'Connor; Andrew N Phillips; Jason V Baker; Michael J Vjecha; Marcelo H Losso; Hartwig Klinker; Gustavo Lopardo; Ian Williams; Jens D Lundgren
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240

9.  D-dimer levels on admission and all-cause mortality risk in COVID-19 patients: a meta-analysis.

Authors:  Daniel Martin Simadibrata; Anna Mira Lubis
Journal:  Epidemiol Infect       Date:  2020-09-07       Impact factor: 2.451

10.  Molecular mechanisms for thrombosis risk in Black people: a role in excess mortality from COVID-19.

Authors:  Roshan Ramasamy; Kate Milne; Deanne Bell; Simon Stoneham; Timothy Chevassut
Journal:  Br J Haematol       Date:  2020-06-08       Impact factor: 8.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.